| Pervasis drug candidate gets EU orphan drug status - Mass High Tech |
|
|
Mass High Tech Pervasis Therapeutics Inc. has won orphan drug designation from the European Commission for its lead drug Vascugel, a prevention treatment of kidney dialysis access failure in patients with end stage renal disease (ESRD). ... Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent |